Top Markets
Coin of the day
Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares

NNNN
Classement en actions #16102
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main,... Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.
Prix de l'action
$7.15
Capitalisation boursière
$313.60M
Changement (1 jour)
-2.12%
Changement (1 an)
-84.14%
Pays
DE
Échange Anbio Biotechnology Class A Ordinary Shares (NNNN)

Catégorie

EPS pour Anbio Biotechnology Class A Ordinary Shares (NNNN)
EPS au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Anbio Biotechnology Class A Ordinary Shares, l’EPS actuel de la société (TTM) est de 0. À la fin de 2026, la société avait un EPS de 0 égal à celui de 2026, qui était de 0.
Historique de l'EPS de Anbio Biotechnology Class A Ordinary Shares de 2026 à 2026
EPS à la fin de chaque année
Année EPS Changez
Pas assez de données pour les dates fournies.
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
$8.85 -
US
$6.41 -
FR
- -
JP
$3.32 -
US
- -
CH